These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 8366824)
1. Outer membrane proteins and lipopolysaccharide changes after exposure of Pseudomonas aeruginosa to antibacterial drugs. Giordano A; Magni A; Trancassini M; Cipriani P New Microbiol; 1993 Jul; 16(3):281-6. PubMed ID: 8366824 [TBL] [Abstract][Full Text] [Related]
2. Influence of aztreonam-netilmicin association on outer membrane proteins of P. aeruginosa strains. Cipriani P; Giordano A; Magni A; Filadoro F Microbiologica; 1991 Oct; 14(4):301-5. PubMed ID: 1663572 [TBL] [Abstract][Full Text] [Related]
3. Subinhibitory concentrations of antibacterial drugs and Pseudomonas aeruginosa virulence factors. Trancassini M; Giordano A; Magni A; Cipriani P New Microbiol; 1993 Jul; 16(3):275-9. PubMed ID: 8366823 [TBL] [Abstract][Full Text] [Related]
4. Outer membrane alterations in Pseudomonas aeruginosa after five-day exposure to quinolones and carbapenems. Cipriani P; Giordano A; Magni A; Papa F; Filadoro F Drugs Exp Clin Res; 1995; 21(4):139-44. PubMed ID: 8529526 [TBL] [Abstract][Full Text] [Related]
5. Effects of continuous exposure to ciprofloxacin on the outer membrane of P. aeruginosa. Magni A; Giordano A; Papa F; de Vito D; Cipriani P New Microbiol; 1994 Oct; 17(4):307-12. PubMed ID: 7861986 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics. Werneburg M; Zerbe K; Juhas M; Bigler L; Stalder U; Kaech A; Ziegler U; Obrecht D; Eberl L; Robinson JA Chembiochem; 2012 Aug; 13(12):1767-75. PubMed ID: 22807320 [TBL] [Abstract][Full Text] [Related]
7. Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity. Tateda K; Ishii Y; Hirakata Y; Matsumoto T; Ohno A; Yamaguchi K J Antimicrob Chemother; 1994 Dec; 34(6):931-42. PubMed ID: 7730236 [TBL] [Abstract][Full Text] [Related]
8. Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy. Pagani L; Landini P; Luzzaro F; Debiaggi M; Romero E Microbiologica; 1990 Jan; 13(1):43-53. PubMed ID: 2155376 [TBL] [Abstract][Full Text] [Related]
9. In vitro effect of combinations of netilmicin with aztreonam against Pseudomonas aeruginosa. Tumah H; Velonaki A; Michalitsianos D; Legakis N Chemioterapia; 1987 Jun; 6(2 Suppl):128-9. PubMed ID: 3151332 [No Abstract] [Full Text] [Related]
10. Outer membrane proteins profiles of Pseudomonas aeruginosa after the post-antibiotic effect of imipenem. Hostacká A; Karelová E Microbios; 1997; 90(362):45-50. PubMed ID: 9301070 [TBL] [Abstract][Full Text] [Related]
11. High temperature induced antibiotic sensitivity changes in Pseudomonas aeruginosa. Bhatti AR; Kumar K; Stobo C; Chaudhry GR; Ingram JM Microbios; 1999; 97(387):103-15. PubMed ID: 10453485 [TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibilities of mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients against azthreonam, netilmicin and piperacillin. Flournoy DJ; Cox FR Methods Find Exp Clin Pharmacol; 1984 Sep; 6(9):487-9. PubMed ID: 6439964 [TBL] [Abstract][Full Text] [Related]
13. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa. Oie S; Uematsu T; Sawa A; Mizuno H; Tomita M; Ishida S; Okano Y; Kamiya A J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851 [TBL] [Abstract][Full Text] [Related]
15. Postantibiotic effect of norfloxacin and its influence on profiles of outer membrane proteins of Pseudomonas aeruginosa. Hostacká A; Karelová E Pharmazie; 1997 Mar; 52(3):238-9. PubMed ID: 9109171 [TBL] [Abstract][Full Text] [Related]
16. Effect of outer membrane permeabilisation on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa. Champlin FR; Ellison ML; Bullard JW; Conrad RS Int J Antimicrob Agents; 2005 Aug; 26(2):159-164. PubMed ID: 16040235 [TBL] [Abstract][Full Text] [Related]
17. The interaction between Pseudomonas aeruginosa cells and cationic PC:Chol:DOTAP liposomal vesicles versus outer-membrane structure and envelope properties of bacterial cell. Drulis-Kawa Z; Dorotkiewicz-Jach A; Gubernator J; Gula G; Bocer T; Doroszkiewicz W Int J Pharm; 2009 Feb; 367(1-2):211-9. PubMed ID: 18952159 [TBL] [Abstract][Full Text] [Related]
18. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones]. Lei YC; Wang HB; Sun ZY; Shen ZY Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918 [TBL] [Abstract][Full Text] [Related]
19. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin]. Wundt W; Lange KP; Baumgärtner M Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123 [TBL] [Abstract][Full Text] [Related]
20. The problems in the outer membrane permeability and the antibiotic resistance of Pseudomonas aeruginosa. Nakae T Kitasato Arch Exp Med; 1991 Sep; 64(2-3):115-21. PubMed ID: 1667326 [No Abstract] [Full Text] [Related] [Next] [New Search]